Literature DB >> 19135728

Purinergic signalling in inflammation of the central nervous system.

Francesco Di Virgilio1, Stefania Ceruti, Placido Bramanti, Maria P Abbracchio.   

Abstract

Inflammation is the most fundamental body reaction to noxious stimuli. No vascularized tissue, organ or apparatus is free from this response. Several mediators of inflammation, originating from outside (exogenous) or inside (endogenous) the body, are known. Among the endogenous factors, extracellular nucleotides and nucleosides are attracting interest for their ubiquity and striking ability to modulate diverse immune responses. Until recently, it was doubted that the central nervous system (CNS), reportedly an 'immunoprivileged organ', could be the site of immune reactions. Nowadays, it is acknowledged that inflammation and immunity have a key role in a vast range of CNS diseases. Likewise, it is clear that purinergic signalling profoundly affects neuroinflammation. Here, we provide a brief update of the state of the art in this expanding field.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19135728     DOI: 10.1016/j.tins.2008.11.003

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  89 in total

1.  Purinergic signaling: a fundamental mechanism in neutrophil activation.

Authors:  Yu Chen; Yongli Yao; Yuka Sumi; Andrew Li; Uyen Kim To; Abdallah Elkhal; Yoshiaki Inoue; Tobias Woehrle; Qin Zhang; Carl Hauser; Wolfgang G Junger
Journal:  Sci Signal       Date:  2010-06-08       Impact factor: 8.192

2.  Chronic mild hyperhomocysteinemia alters ectonucleotidase activities and gene expression of ecto-5'-nucleotidase/CD73 in rat lymphocytes.

Authors:  Emilene B S Scherer; Luiz Eduardo B Savio; Fernanda C Vuaden; Andréa G K Ferreira; Maurício R Bogo; Carla D Bonan; Angela T S Wyse
Journal:  Mol Cell Biochem       Date:  2011-11-02       Impact factor: 3.396

3.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

Review 4.  Purinergic signaling: a novel mechanism in immune surveillance.

Authors:  Lin Mei; Wei Du; Wei Gao; Qi-bing Mei
Journal:  Acta Pharmacol Sin       Date:  2010-08-16       Impact factor: 6.150

5.  Purine receptors and Ca(2+) signalling in the human blood-brain barrier endothelial cell line hCMEC/D3.

Authors:  Willem Bintig; Daniela Begandt; Barbara Schlingmann; Linda Gerhard; Maria Pangalos; Lutz Dreyer; Natalija Hohnjec; Pierre-Olivier Couraud; Ignacio A Romero; Babette B Weksler; Anaclet Ngezahayo
Journal:  Purinergic Signal       Date:  2011-09-29       Impact factor: 3.765

Review 6.  Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.

Authors:  Fernando Ochoa-Cortes; Fabio Turco; Andromeda Linan-Rico; Suren Soghomonyan; Emmett Whitaker; Sven Wehner; Rosario Cuomo; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

7.  Expression of ecto-nucleoside triphosphate diphosphohydrolase1-3 (NTPDase1-3) by cortical astrocytes after exposure to pro-inflammatory factors in vitro.

Authors:  Dusica Brisevac; Aleksandar Bajic; Ivana Bjelobaba; Milena Milosevic; Mirjana Stojiljkovic; Cordian Beyer; Tim Clarner; Markus Kipp; Nadezda Nedeljkovic
Journal:  J Mol Neurosci       Date:  2013-08-29       Impact factor: 3.444

8.  ATP differentially upregulates fibroblast growth factor 2 and transforming growth factor α in neonatal and adult mice: effect on neuroproliferation.

Authors:  C Jia; A R Cussen; C C Hegg
Journal:  Neuroscience       Date:  2010-12-25       Impact factor: 3.590

9.  Acetate supplementation increases brain phosphocreatine and reduces AMP levels with no effect on mitochondrial biogenesis.

Authors:  Dhaval P Bhatt; Heidi M Houdek; John A Watt; Thad A Rosenberger
Journal:  Neurochem Int       Date:  2013-01-12       Impact factor: 3.921

Review 10.  ATP signaling in brain: release, excitotoxicity and potential therapeutic targets.

Authors:  Abraham Cisneros-Mejorado; Alberto Pérez-Samartín; Miroslav Gottlieb; Carlos Matute
Journal:  Cell Mol Neurobiol       Date:  2014-08-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.